Basics PDS Biotechnology Corporation IPO Date: October 2, 2015 Sector: Healthcare Industry: Biotech Market Cap: $64.45M Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 4.21% Avg Daily Range (30 D): $0.06 | 4.17% Avg Daily Range (90 D): $0.06 | 4.49% Institutional Daily Volume Avg Daily Volume: .58M Avg Daily Volume (30 D): .54M Avg Daily Volume (90 D): .55M Trade Size Avg Trade Size (Sh.): 183 Avg Trade Size (Sh.) (30 D): 266 Avg Trade Size (Sh.) (90 D): 246 Institutional Trades Total Inst.Trades: 24 Avg Inst. Trade: $2.05M Avg Inst. Trade (30 D): $4.33M Avg Inst. Trade (90 D): $4.33M Avg Inst. Trade Volume: .37M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.39M Avg Closing Trade (30 D): $7.82M Avg Closing Trade (90 D): $7.82M Avg Closing Volume: 835.3K     News Dec 6, 2024 @ 1:00 PM PDS Biotechnology Reports Inducement Grant Under N... Source: N/A Oct 2, 2024 @ 12:00 PM PDS Biotech Announces 36-Month Overall Survival Ra... Source: N/A Sep 9, 2024 @ 12:00 PM PDS Biotech to Present Updated VERSATILE-002 Data ... Source: N/A May 9, 2024 @ 9:46 PM PDS Biotech VERSATILE-002 Phase 2 Clinical Trial M... Source: PDS Biotechnology Corporation May 3, 2024 @ 12:00 PM PDS Biotechnology Announces Details of Virtual KOL... Source: PDS Biotechnology Corporation Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.94 $-.21 $-.21 Diluted EPS $-.94 $-.21 $-.21 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -35.5M $ -8.49M $ -7.95M Operating Income / Loss $ -35.33M $ -9.11M $ -7.36M Cost of Revenue $ $ $ Net Cash Flow $ -14.87M $ M $ -8.06M PE Ratio     Splits Mar 18, 2019:   1:20